Jochen J Frietsch

12PUBLICATIONS
66CO-AUTHORS
Haematological tumoursPsychology of ageingPredictive and prognostic markersPsychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Aug 10, 2026
Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany-A prospective, multicentre trial.

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Dec 27, 2022
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.

Jochen J Frietsch, Sarah Flossdorf, James F Beck

|May 10, 2022
Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma.

Jochen J Frietsch, Jenny Miethke, Paul Linke

|Oct 21, 2021
Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms.

Samantha O'Hagan Henderson, Jochen J Frietsch, Inken Hilgendorf

Pageof 2

Frequent Collaborators

4 joint publications

Inken Hilgendorf

2 joint publications

Andreas B Herrmann

2 joint publications

Otmar Huber

2 joint publications

Andreas Hochhaus